Moderna, Inc. insider trading

MRNANASDAQ

$190.01+1.07 (+0.57%)as of Oct 2, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (+569.8%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
Date	Category	Person	Role	Action	Amount	Change in holding

Open market purchase

Open market sell

Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium

Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Unlock quarterly net flow

Key players

SBStephane BancelChief Executive Officer5.5646%of company
NANoubar AfeyanDirector1.7173%of company
SHStephen HogePresident0.4303%of company
PSPaul SaganDirector0.1238%of company
STShannon Thyme KlingerChief Legal Officer0.0204%of company
JMJames M. MockChief Financial Officer0.0149%of company
FNFrancois NaderDirector0.0082%of company
EGElizabeth G. NabelDirector0.0048%of company
SHSandra HorningDirector0.0047%of company
AHAbbas HussainDirector0.003%of company

AI Activity Analysis

Premium

Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto

Company	Insider / role	Action	ΔOwn	Avg price	Amount
MRNA	Abbas HussainDirector	Open market sell$265K	-32.0%	$46.63	$265K	May 1, 2026	May 4, 2026
MRNA	Abbas HussainDirector	Open market sell$13.9K	-25.0%	$27.60	$13.9K	Dec 9, 2025	Dec 11, 2025

End of history · 2 transactions